Home › Funds › Birchview Capital, LP › QNCX

Birchview Capital, LP position in QNCX

QUINCE THERAPEUTICS INC · Health Care

Birchview Capital, LP reported holding 40,601 shares of QNCX (QUINCE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.75% of its reported portfolio and ranking #33 among its reported holdings. Birchview Capital, LP first reported this position in Q3 2026.

Latest position (Q3 2026)40.60K sh
Reported value held$1.26M
Portfolio Weight0.75%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's QNCX position evolved

Birchview Capital, LP first disclosed a stake in QNCX in Q3 2026 at 40,601 shares (US$1.3M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 40.60K $1.26M New

About QNCX and 13F data

QNCX (QUINCE THERAPEUTICS INC) is a Health Care company. 17 other funds we track also report a position in QNCX — the largest reported positions include Squadron Capital Management LLC (US$734K), Cormorant Asset Management, LP (US$100K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QNCX

All QNCX fund holders →

FAQ

How long has Birchview Capital, LP held QNCX?

Birchview Capital, LP has disclosed QNCX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Birchview Capital, LP's current position in QNCX?

As of Q3 2026, Birchview Capital, LP holds 40.60K shares of QNCX (QUINCE THERAPEUTICS INC), valued at $1.26M, representing 0.75% of its reported portfolio and ranking #33.

Has Birchview Capital, LP been buying or selling QNCX?

In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in QNCX.

Which other funds hold QNCX?

Other major institutional holders of QNCX include Squadron Capital Management LLC, Cormorant Asset Management, LP, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.